Cannabis use and dependence among French schizophrenic inpatients

Frontiers in Psychiatry

Volumn 5, Issue JUL, 2014, Pages

  Lejoyeux, Michel ^a   Basquin, Anne ^a   Koch, Marie ^a   Embouazza, Houcine ^a   Chalvin, Florence ^a   Ilongo, Michaelle ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Addiction; Alcohol; Alcohol dependence; Cannabis; Compulsive buying; Dependence; Nicotine; Pathological gambling

Indexed keywords

ALCOHOL; CANNABIS; OPIATE;

ADULT; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; COMPULSION; CUT ANNOYED GUILTY EYE OPENER QUESTIONNAIRE; DISEASE ASSOCIATION; DSM-IV-TR; ETHNIC GROUP; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; FRENCH LANGUAGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPIATE ADDICTION; PATHOLOGICAL GAMBLING; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 84904472793     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00082     Document Type: Article

References (21)

1. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, et al. The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. Schizophr Res (2008) 100:39-52. doi: 10.1016/j.schres.2007.11.034
2. van Dijk D, Koeter MJW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophr Res (2012) 137:50-7. doi:10.1016/j.schres.2012.01.016
3. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull (2010) 36:1115-30. doi:10.1093/schbul/sbp031
4. Kuepper R, Morrison PD, van Os J, Murray RM, Kenis G, Henquet C. Does dopamine mediate the psychosis-inducing effect of cannabis? A review and integration of findings across disciplines. Schizophr Res (2010) 121(1-3):107-17. doi:10.1016/j.schres.2010.05.031
5. Matthew Koola M, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, et al. Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry Res (2013) 209(3):273-8. doi:10.1016/j.psychres.2013.07.044
6. Burns JK. Pathways from cannabis to psychosis: a review of the evidence. Front Psychiatry (2013) 4:128. doi:10.3389/fpsyt.2013.00128
7. Foti DJ, Kotov R, Guey LT, Bromet EJ. Cannabis use and the course of schizophrenia: 10-year follow up after first hospitalization. Am J Psychiatry (2010) 167:987-93. doi:10.1176/appi.ajp.2010.09020189
8. Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, et al. A study investigating the acute dose-response effects of 13 mg and 17 mg delta 9-tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. J Psychopharmacol (2008) 22:441-51. doi:10.1177/0269881108088194
9. Sheehan DV, Lecrubier Y, Harnett Sheehan K. The validity of the mini international neuropsychiatric interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry (1997) 12:232-41. doi:10.1016/S0924-9338(97)83297-X
10. Saliou V, Fichelle A, Mc Loughlin M, Thauvin I, Lejoyeux M. Psychiatric disorders among patients admitted to a French medical emergency service. Gen Hosp Psychiatry (2005) 27:263-8. doi:10.1016/j.genhosppsych.2005.03.009
11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 13:261-76. doi:10.1093/schbul/13.2.261
12. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res (1988) 23:99-110. doi:10.1016/0165-1781(88)90038-8
13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 134:382-9. doi:10.1192/bjp.134.4.382
14. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol (1959) 32:50-5. doi:10.1111/j.2044-8341.1959.tb00467.x
15. Achour F, Brun P, Mc Loughlin M, Adès J, Lejoyeux M. Lifestyle characteristics of patients admitted to a French medical emergency service. Alcohol Res (2004) 9(4):167-70.
16. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med (1989) 12(2):159-82. doi:10.1007/BF00846549
17. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA (1984) 252(14):1905-7. doi:10.1001/jama.1984.03350140051025
18. Lejoyeux M, Weinstein A. Compulsive buying. Am J Drug Alcohol Abuse (2010) 36(5):248-53. doi:10.3109/00952990.2010.493590
19. de Beaurepaire R, Lukasiewicz M, Beauverie P, Castera S, Dagorne O. Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. Eur Psychiatry (2007) 22:540-8. doi:10.1016/j.eurpsy.2007.05.001
20. Lejoyeux M, Gastal D, Bergeret A, Casalino E, Lequen V, Guillermet S. Alcohol use disorders among patients examined in emergency departments after a suicide attempt. Eur Addict Res (2012) 18:26-33. doi:10.1159/000332233
21. Bernstein E, Bernstein J, Levenson S. Project ASSERT: an ED based intervention to increase access to primary care, preventive services, and the substance abuse system. Ann Emerg Med (1997) 30:181-9. doi:10.1016/S0196-0644(97)70140-9